Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
25
Number of overlapping holdings
19.4%
% of XBI's 129 holdings also in HELX
44.6%
% of HELX's 62 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus HELX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 2.9% | 5.3% | 2.9% |
|
NATERA INC | 2.6% | 3.1% | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% | 5.6% | 2.6% |
|
SAREPTA THERAPEUTICS INC | 2.6% | 1.8% | 1.8% |
|
UNITED THERAPEUTICS CORP | 3.2% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to HELX
|
GILEAD SCIENCES INC | 3.0% |
|
ABBVIE INC | 2.9% |
|
VIKING THERAPEUTICS, INC. | 2.9% |
|
AMGEN INC | 2.8% |
|
BIOMARIN PHARMACEUTICAL INC | 2.7% |
|
EXACT SCIENCES CORP | 2.6% |
|
INCYTE CORP | 2.5% |
|
BIOGEN IDEC INC | 2.2% |
|
CYTOKINETICS INC | 2.0% |
|
UNITED THERAPEUTICS CORP | 1.5% |
XBI Underweight Relative to HELX
|
MEDPACE HOLDINGS, INC. | -6.4% |
|
DANAHER CORP | -5.2% |
|
THERMO FISHER SCIENTIFIC INC | -4.9% |
|
ELI LILLY & CO | -4.2% |
|
KRYSTAL BIOTECH, INC. | -3.9% |
 |
SAMSUNG BIOLOGICS CO., LTD. | -3.3% |
|
VERTEX PHARMACEUTICALS INC | -3.0% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.6% |
|
BRUKER CORP | -2.4% |
|
REGENERON PHARMACEUTICALS | -2.4% |